IB Acquisition Corp. (IBACR) stock
IBACRNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends September 30Also trades as IBAC
$0.10−0.00 (-3.50%)
Close on Oct 30, 2026Market cap $54.39MP/E –Yield –
IB Acquisition r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for IB Acquisition
IB Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.